Acrivon Therapeutics CLO Mary Miller Sells $1,008 in Company Stock
Mary Miller, Chief Legal Officer at Acrivon Therapeutics, Inc. (NASDAQ:ACRV), executed a $1,008 sale of the company's common stock on July 21, 2026. The transaction involved the automatic disposition of 573 shares at $1.76 each to satisfy mandatory tax withholding requirements triggered by the vesting of restricted stock units. Following the transa…